| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.23 | 8e-07 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |